Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

NMR-based newborn urine screening for optimized detection of inherited errors of metabolism.

Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Ansó S, Echevarría LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MÁ, Legorburu AP, Fang F, Astigarraga I, Schäfer H, Spraul M, Millet O.

Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.

2.

[Protocol for the study and treatment of primary immune thrombocytopenia: PTI-2018].

Monteagudo E, Astigarraga I, Cervera Á, Dasí MA, Sastre A, Berrueco R, Dapena JL; en representación del Grupo de Trabajo de la PTI de la Sociedad Española de Hematología y Oncología Pediátricas (SEHOP).

An Pediatr (Barc). 2019 Aug;91(2):127.e1-127.e10. doi: 10.1016/j.anpedi.2019.04.014. Epub 2019 Jun 6. Spanish.

3.

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.

Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagué O, Celis V, Verdu-Amoros J, Nadeu F, Sábado C, Ferrández A, Garrido M, García-Bragado F, de la Maya MD, Vagace JM, Panizo CM, Astigarraga I, Andrés M, Jaffe ES, Campo E, Salaverria I.

Haematologica. 2019 Sep;104(9):1822-1829. doi: 10.3324/haematol.2018.207928. Epub 2019 Feb 7.

4.

Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.

Martin-Guerrero I, Gutierrez-Camino A, Echebarria-Barona A, Astigarraga I, Garcia de Andoin N, Navajas A, Garcia-Orad A.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0081-5. [Epub ahead of print]

PMID:
30723315
5.

A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.

Chellapandian D, Hines MR, Zhang R, Jeng M, van den Bos C, Santa-María López V, Lehmberg K, Sieni E, Wang Y, Nakano T, Williams JA, Fustino NJ, Astigarraga I, Dunkel IJ, Abla O, van Halteren AGS, Pei D, Cheng C, Weitzman S, Sung L, Nichols KE.

Cancer. 2019 Mar 15;125(6):963-971. doi: 10.1002/cncr.31893. Epub 2018 Dec 6.

PMID:
30521100
6.

Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.

Gutierrez-Camino Á, Umerez M, Lopez-Lopez E, Santos-Zorrozua B, Martin-Guerrero I, de Andoin NG, Ana S, Navajas A, Astigarraga I, Garcia-Orad A.

Pharmacogenomics. 2018 Dec;19(18):1403-1412. doi: 10.2217/pgs-2018-0113.

PMID:
30479191
7.

Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.

Ehl S, Astigarraga I, von Bahr Greenwood T, Hines M, Horne A, Ishii E, Janka G, Jordan MB, La Rosée P, Lehmberg K, Machowicz R, Nichols KE, Sieni E, Wang Z, Henter JI.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1508-1517. doi: 10.1016/j.jaip.2018.05.031. Epub 2018 Jul 4. Review.

PMID:
30201097
8.

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis.

Lucchini G, Marsh R, Gilmour K, Worth A, Nademi Z, Rao A, Booth C, Amrolia P, Silva J, Chiesa R, Wynn R, Lehmberg K, Astigarraga I, Güngör T, Stary J, Moshous D, Ifversen M, Zinn D, Jordan M, Kumar A, Yasumi T, Veys P, Rao K.

Blood. 2018 Nov 8;132(19):2088-2096. doi: 10.1182/blood-2018-01-827485. Epub 2018 Aug 13.

PMID:
30104219
9.

CD300c costimulates IgE-mediated basophil activation, and its expression is increased in patients with cow's milk allergy.

Zenarruzabeitia O, Vitallé J, Terrén I, Orrantia A, Astigarraga I, Dopazo L, Gonzalez C, Santos-Díez L, Tutau C, Gamboa PM, Bilbao A, Borrego F.

J Allergy Clin Immunol. 2019 Feb;143(2):700-711.e5. doi: 10.1016/j.jaci.2018.05.022. Epub 2018 Jun 12.

PMID:
29906528
10.

Infantile Pulmonary Teratoid Tumor.

de Kock L, Fahiminiya S, Fiset PO, Astigarraga I, Nguyen VH, Albrecht S, Foulkes WD.

N Engl J Med. 2018 Jun 7;378(23):2238-2240. doi: 10.1056/NEJMc1803354. No abstract available.

PMID:
29874541
11.

[Haemophagocytic syndromes: The importance of early diagnosis and treatment].

Astigarraga I, Gonzalez-Granado LI, Allende LM, Alsina L.

An Pediatr (Barc). 2018 Aug;89(2):124.e1-124.e8. doi: 10.1016/j.anpedi.2018.05.003. Epub 2018 Jun 2. Review. Spanish.

12.

Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk.

Gutierrez-Camino A, Martin-Guerrero I, Dolzan V, Jazbec J, Carbone-Bañeres A, Garcia de Andoin N, Sastre A, Astigarraga I, Navajas A, Garcia-Orad A.

Oncotarget. 2018 May 1;9(33):22907-22914. doi: 10.18632/oncotarget.25144. eCollection 2018 May 1.

13.

Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity.

Gutierrez-Camino A, Umerez M, Santos B, Martin-Guerrero I, García de Andoin N, Sastre A, Navajas A, Astigarraga I, Garcia-Orad A.

Epigenomics. 2018 Apr 1;10(4):409-417. doi: 10.2217/epi-2017-0138. Epub 2018 Mar 23.

PMID:
29569486
14.

Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.

Umerez M, Garcia-Obregon S, Martin-Guerrero I, Astigarraga I, Gutierrez-Camino A, Garcia-Orad A.

Pharmacogenomics. 2018 Mar;19(4):361-373. doi: 10.2217/pgs-2017-0164. Epub 2018 Feb 22. Review.

PMID:
29469670
15.

Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.

Gutierrez-Camino Á, Umerez M, Martin-Guerrero I, García de Andoin N, Santos B, Sastre A, Echebarria-Barona A, Astigarraga I, Navajas A, Garcia-Orad A.

Pharmacogenomics J. 2018 Dec;18(6):704-712. doi: 10.1038/s41397-017-0003-3. Epub 2017 Dec 27.

PMID:
29282364
16.

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Bergsten E, Horne A, Aricó M, Astigarraga I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Montgomery S, Nanduri V, Rosso D, Henter JI.

Blood. 2017 Dec 21;130(25):2728-2738. doi: 10.1182/blood-2017-06-788349. Epub 2017 Sep 21.

17.

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.

Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

J Pediatr. 2017 Oct;189:72-78.e3. doi: 10.1016/j.jpeds.2017.06.005. Epub 2017 Aug 12.

PMID:
28807357
18.

Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients.

Garcia-Obregon S, Azkargorta M, Seijas I, Pilar-Orive J, Borrego F, Elortza F, Boyano MD, Astigarraga I.

J Microbiol Immunol Infect. 2018 Aug;51(4):465-472. doi: 10.1016/j.jmii.2016.12.002. Epub 2017 Jun 13.

19.

Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.

Gutierrez-Camino A, Martin-Guerrero I, Garcia de Andoin N, Sastre A, Carbone Bañeres A, Astigarraga I, Navajas A, Garcia-Orad A.

PLoS One. 2017 May 8;12(5):e0177421. doi: 10.1371/journal.pone.0177421. eCollection 2017.

20.

[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].

Bautista F, Gallego S, Cañete A, Mora J, Díaz de Heredia C, Cruz O, Fernández JM, Rives S, Berlanga P, Hladun R, Juan Ribelles A, Madero L, Ramírez M, Fernández Delgado R, Pérez-Martínez A, Mata C, Llort A, Martín Broto J, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L; en nombre de la Sociedad Española de Oncología Pediátrica (SEHOP) y el Grupo de Nuevas Terapias en Oncología Pediátrica; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP) and the New Drug Development Group in Pediatric Oncology.

An Pediatr (Barc). 2017 Sep;87(3):155-163. doi: 10.1016/j.anpedi.2016.07.007. Epub 2017 Mar 6. Spanish.

21.

Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma.

Zenarruzabeitia O, Vitallé J, Astigarraga I, Borrego F.

Clin Cancer Res. 2017 Feb 1;23(3):615-617. doi: 10.1158/1078-0432.CCR-16-2478. Epub 2016 Nov 21.

22.

MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.

Iparraguirre L, Gutierrez-Camino A, Umerez M, Martin-Guerrero I, Astigarraga I, Navajas A, Sastre A, Garcia de Andoin N, Garcia-Orad A.

Pharmacogenet Genomics. 2016 Nov;26(11):517-525.

PMID:
27649261
23.

The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults.

Zenarruzabeitia O, Vitallé J, García-Obregón S, Astigarraga I, Eguizabal C, Santos S, Simhadri VR, Borrego F.

Sci Rep. 2016 Sep 6;6:32693. doi: 10.1038/srep32693.

24.

[Empowerment of patients and physicians' role in the long-term follow-up survivors of childhood cancer].

Astigarraga I, Calvo-Escribano C, Ramírez-Villar GL, Márquez-Vega C.

Med Clin (Barc). 2016 Dec 2;147(11):511-515. doi: 10.1016/j.medcli.2016.06.017. Epub 2016 Jul 21. Spanish. No abstract available.

PMID:
27452306
25.

Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.

Lopez-Lopez E, Gutierrez-Camino A, Astigarraga I, Navajas A, Echebarria-Barona A, Garcia-Miguel P, Garcia de Andoin N, Lobo C, Guerra-Merino I, Martin-Guerrero I, Garcia-Orad A.

Pharmacogenomics. 2016 May;17(7):731-41. doi: 10.2217/pgs-2016-0001. Epub 2016 May 16.

PMID:
27180762
26.

Somatic DICER1 mutations in adult-onset pulmonary blastoma.

de Kock L, Bah I, Brunet J, Druker H, Astigarraga I, Bosch-Barrera J, Soglio DB, Nguyen VH, Malkin D, Priest JR, Foulkes WD.

Eur Respir J. 2016 Jun;47(6):1879-82. doi: 10.1183/13993003.00172-2016. Epub 2016 Apr 28. No abstract available.

27.

Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.

Iskrov G, Astigarraga I, Stefanov R, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Schieppati A, Taruscio D, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network.

Eur J Health Econ. 2016 Apr;17 Suppl 1:67-78. doi: 10.1007/s10198-016-0790-5. Epub 2016 Apr 4.

PMID:
27042831
28.

Landscape of early clinical trials for childhood and adolescence cancer in Spain.

Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz O, Fernández JM, Rives S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L.

Clin Transl Oncol. 2016 Jul;18(7):708-13. doi: 10.1007/s12094-015-1421-9. Epub 2015 Oct 21.

PMID:
26489424
29.

Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.

Chellapandian D, Shaikh F, van den Bos C, Somers GR, Astigarraga I, Jubran R, Degar B, Carret AS, Mandel K, Belletrutti M, Dix D, Visser J, Abuhadra N, Chang T, Rollins B, Whitlock J, Weitzman S, Abla O.

Pediatr Blood Cancer. 2015 Dec;62(12):2162-6. doi: 10.1002/pbc.25645. Epub 2015 Jul 14.

PMID:
26179251
30.

Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.

Aricò M, Astigarraga I, Braier J, Donadieu J, Gadner H, Glogova E, Grois N, Henter JI, Janka G, McClain KL, Ladisch S, Pötschger U, Rosso D, Thiem E, Weitzman S, Windebank K, Minkov M; Histiocyte Society.

Br J Haematol. 2015 Apr;169(2):241-8. doi: 10.1111/bjh.13271. Epub 2014 Dec 18.

PMID:
25522229
31.

[Advances and challenges in the fight against childhood cancer].

Astigarraga I.

An Pediatr (Barc). 2015 Feb;82(2):57-8. doi: 10.1016/j.anpedi.2014.11.001. Epub 2014 Dec 10. Spanish. No abstract available.

32.

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

Arthritis Rheumatol. 2014 Oct;66(10):2871-80. doi: 10.1002/art.38769.

33.

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S; Histiocyte Society.

Blood. 2013 Jun 20;121(25):5006-14. doi: 10.1182/blood-2012-09-455774. Epub 2013 Apr 15.

34.

Clinical features of influenza disease in admitted children during the first postpandemic season and risk factors for hospitalization: a multicentre Spanish experience.

Launes C, García-García JJ, Martínez-Planas A, Moraga F, Soldevila N, Astigarraga I, Arístegui J, Korta J, Quintana JM, Torner N, Domínguez A; CIBERESP Cases and Controls in Pandemic Influenza Working Group.

Clin Microbiol Infect. 2013 Mar;19(3):E157-62. doi: 10.1111/1469-0691.12106. Epub 2013 Jan 10.

35.

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, Egeler RM, Janka G, Micic D, Rodriguez-Galindo C, Van Gool S, Visser J, Weitzman S, Donadieu J; Euro Histio Network.

Pediatr Blood Cancer. 2013 Feb;60(2):175-84. doi: 10.1002/pbc.24367. Epub 2012 Oct 25.

36.

2009 H1N1: risk factors for hospitalization in a matched case-control study.

Launes C, García-García JJ, Martínez-Planas A, Moraga F, Astigarraga I, Arístegui J, Korta J, Salado C, Quintana JM, Soldevila N, Domínguez A; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.

Eur J Pediatr. 2012 Jul;171(7):1127-31. doi: 10.1007/s00431-012-1716-6. Epub 2012 Mar 21.

PMID:
22430351
37.

[Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010].

Monteagudo E, Fernández-Delgado R, Sastre A, Toll T, Llort A, Molina J, Astigarraga I, Dasí MA, Cervera A; Grupo de Trabajo de la PTI de la Sociedad Española de Hematología y Oncología Pediátricas.

An Pediatr (Barc). 2011 Jun;74(6):414.e1-8. doi: 10.1016/j.anpedi.2010.11.004. Epub 2011 Mar 24. Spanish.

38.

Hemophagocytic lymphohistiocytosis in a pancreas-kidney transplant recipient: response to dexamethasone and cyclosporine.

González-Posada JM, Hernández D, Martin A, Raya JM, Pitti S, Bonilla A, Astigarraga I, Alarcó A.

Clin Nephrol. 2008 Jul;70(1):82-6.

PMID:
18793556
39.

[Ophthalmological findings in pediatric brain neoplasms: 58 cases].

Santamaría A, Martínez R, Astigarraga I, Etxebarría J, Sánchez M.

Arch Soc Esp Oftalmol. 2008 Aug;83(8):471-7. Spanish.

40.

Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.

Hügle B, Astigarraga I, Henter JI, Porwit-MacDonald A, Meindl A, Schuster V.

Eur J Pediatr. 2007 Jun;166(6):589-93. Epub 2006 Oct 21.

PMID:
17058098
41.

[Kikuchi-Fujimoto disease: review of four cases].

Montejo M, Lekerika N, Astigarraga I, Aguirrebengoa K, Goikoetxea J, Erdozain JG, Bidaurrazaga N.

An Med Interna. 2006 Apr;23(4):173-5. Spanish.

PMID:
16796410
42.

Near fatal cerebellar swelling in familial hemophagocytic lymphohistiocytosis.

Astigarraga I, Prats JM, Navajas A, Fernández-Teijeiro A, Urberuaga A.

Pediatr Neurol. 2004 May;30(5):361-4.

PMID:
15165642
43.

Reversible cardiomyopathy secondary to alpha-interferon in an infant.

Angulo MP, Navajas A, Galdeano JM, Astigarraga I, Fernández-Teijeiro A.

Pediatr Cardiol. 1999 Jul-Aug;20(4):293-4.

PMID:
10368457
44.

[Vaccination of chickenpox in children with acute lymphoblastic leukaemia].

Navajas A, Astigarraga I, Fernández-Teijeiro A, Aga M, Redondo ML, Roig A, Corral J.

Enferm Infecc Microbiol Clin. 1999 Apr;17(4):162-5. Spanish.

PMID:
10365508
45.

Hypereosinophilia due to myiasis.

Navajas A, Cardenal I, Piñan MA, Ortiz A, Astigarraga I, Fdez-Teijeiro A.

Acta Haematol. 1998;99(1):27-30.

PMID:
9490562
46.

[An immunodepressed girl with acute bilateral pneumopathy].

Angulo MP, Astigarraga I, Fernández-Teijeiro A, Navajas A.

An Esp Pediatr. 1997 Feb;46(2):205-6. Spanish. No abstract available.

PMID:
9157815
47.

Hydrops fetalis and fibrosarcoma: case report of an uncommon association.

Navajas A, Astigarraga I, Fernández-Teijeiro A, Lopez-Heredia J, Biritxinaga B, Camarero C.

Eur J Pediatr. 1997 Jan;156(1):62-4.

PMID:
9007494
48.

Secondary central nervous system metastases in children with neuroblastoma.

Astigarraga I, Lejarreta R, Navajas A, Fernandez-Teijeiro A, Imaz I, Bezanilla JL.

Med Pediatr Oncol. 1996 Dec;27(6):529-33.

PMID:
8888812
49.

[Acute lymphoblastic leukemia with L1 morphology arising during treatment for ALL-L3 in a child with AIDS].

Fernández-Teijeiro A, Piñán MA, Cardenal I, Astigarraga I, Navajas A.

Sangre (Barc). 1996 Jun;41(3):245-8. Spanish.

PMID:
8755213
50.

Use of serological markers as a screening test in family members of patients with celiac disease.

Vitoria JC, Arrieta A, Astigarraga I, García-Masdevall D, Rodriguez-Soriano J.

J Pediatr Gastroenterol Nutr. 1994 Oct;19(3):304-9.

PMID:
7815262

Supplemental Content

Loading ...
Support Center